Viewing Study NCT02733159


Ignite Creation Date: 2025-12-24 @ 2:59 PM
Ignite Modification Date: 2026-02-18 @ 1:38 AM
Study NCT ID: NCT02733159
Status: COMPLETED
Last Update Posted: 2025-02-10
First Post: 2016-03-01
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Pembrolizumab in Patients With Non-Small Cell Lung Cancer and a Performance Status 2
Sponsor: University of Birmingham
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-01-04
Start Date Type: ACTUAL
Primary Completion Date: 2023-02-07
Primary Completion Date Type: ACTUAL
Completion Date: 2024-02-05
Completion Date Type: ACTUAL
First Submit Date: 2016-03-01
First Submit QC Date: None
Study First Post Date: 2016-04-11
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2024-07-26
Results First Submit QC Date: None
Results First Post Date: 2025-02-10
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-01-16
Last Update Post Date: 2025-02-10
Last Update Post Date Type: ACTUAL